BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8477008)

  • 1. Possible role of thioformamide as a proximate toxicant in the nephrotoxicity of thiabendazole and related thiazoles in glutathione-depleted mice: structure-toxicity and metabolic studies.
    Mizutani T; Yoshida K; Kawazoe S
    Chem Res Toxicol; 1993; 6(2):174-9. PubMed ID: 8477008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity of thioformamide, a proximate toxicant of nephrotoxic thiazoles, in mice depleted of glutathione.
    Mizutani T; Suzuki K; Murakami M; Yoshida K; Nakanishi K
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):89-101. PubMed ID: 8948017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity of thiazoles structurally related to thiabendazole in mice depleted of glutathione by treatment with buthionine sulfoximine.
    Mizutani T; Yoshida K; Ito K
    Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):29-38. PubMed ID: 1626124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.
    Mizutani T; Yoshida K; Kawazoe S
    Drug Metab Dispos; 1994; 22(5):750-5. PubMed ID: 7835227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of N-methylthiourea, a ring cleavage metabolite, in the hepatotoxicity of methimazole in glutathione-depleted mice: structure-toxicity and metabolic studies.
    Mizutani T; Yoshida K; Murakami M; Shirai M; Kawazoe S
    Chem Res Toxicol; 2000 Mar; 13(3):170-6. PubMed ID: 10725113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
    Mizutani T; Ito K; Nomura H; Nakanishi K
    Food Chem Toxicol; 1990 Mar; 28(3):169-77. PubMed ID: 2344991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex difference in the nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
    Mizutani T; Yoshida K; Ito K; Kawazoe S
    Food Chem Toxicol; 1992 Mar; 30(3):247-50. PubMed ID: 1618448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of thiabendazole (TBZ) on glutathione (GSH) and GSH related enzymes in mice liver].
    Toda C; Yasui T; Hashizume K; Nagano H
    Yakugaku Zasshi; 2000 Sep; 120(9):787-94. PubMed ID: 11019651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative hepatotoxicity of 2-(substituted phenyl)thiazoles and substituted thiobenzamides in mice: evidence for the involvement of thiobenzamides as ring cleavage metabolites in the hepatotoxicity of 2-phenylthiazoles.
    Mizutani T; Suzuki K
    Toxicol Lett; 1996 May; 85(2):101-5. PubMed ID: 8650692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiabendazole (TBZ) nephrotoxicity and recovery in ICR adult mice.
    Tada Y; Fujitani T; Yoneyama M
    Toxicology; 1994; 94(1-3):41-55. PubMed ID: 7801329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity of butylated hydroxytoluene and its analogs in mice depleted of hepatic glutathione.
    Mizutani T; Nomura H; Nakanishi K; Fujita S
    Toxicol Appl Pharmacol; 1987 Jan; 87(1):166-76. PubMed ID: 3798451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute renal toxicity of thiabendazole (TBZ) in ICR mice.
    Tada Y; Fujitani T; Yoneyama M
    Food Chem Toxicol; 1992 Dec; 30(12):1021-30. PubMed ID: 1473796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione and cysteine enhance and diethylmaleate reduces thiabendazole teratogenicity in mice.
    Ogata A; Fujitani T; Yoneyama M; Sasaki M; Suzuki K
    Food Chem Toxicol; 1989 Feb; 27(2):117-23. PubMed ID: 2714716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V; Boyd MR
    Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxicity of eugenol in mice depleted of glutathione by treatment with DL-buthionine sulfoximine.
    Mizutani T; Satoh K; Nomura H; Nakanishi K
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):219-30. PubMed ID: 2047567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of buthionine sulfoximine on orthophenylphenol-induced hepato- and nephrotoxic potential in male rats.
    Nakagawa Y; Tayama K
    Arch Toxicol; 1988; 62(6):452-7. PubMed ID: 3250375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New metabolites of thiabendazole and the metabolism of thiabendazole by mouse embryo in vivo and in vitro.
    Fujitani T; Yoneyama M; Ogata A; Ueta T; Mori K; Ichikawa H
    Food Chem Toxicol; 1991 Apr; 29(4):265-74. PubMed ID: 2040489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.
    Slitt AM; Dominick PK; Roberts JC; Cohen SD
    Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):487-94. PubMed ID: 15910414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subchronic toxicity of thiabendazole (TBZ) in ICR mice.
    Tada Y; Fujitani T; Yoneyama M
    Food Chem Toxicol; 1996 Aug; 34(8):709-16. PubMed ID: 8883472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolic activation of thiabendazole via 5-hydroxythiabendazole: identification of a glutathione conjugate of 5-hydroxythiabendazole.
    Dalvie D; Smith E; Deese A; Bowlin S
    Drug Metab Dispos; 2006 Apr; 34(4):709-17. PubMed ID: 16434547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.